NTR completes $600M sale of its Profertil stake, advancing portfolio realignment and bolstering capital moves from growth to buybacks and debt cuts.
Nutrien (NTR) reported earnings 30 days ago. What's next for the stock?
NTR jumps as strong fertilizer demand, record potash sales and cost cuts fuel its outlook for 2025 growth.
Nutrien Ltd. is rated a Strong Buy, driven by robust nitrogen and potash demand, tight inventories, and favorable global trade dynamics. NTR's vertically integrated model and swift pivot to international potash sales underpin margin expansion and operational resilience. Potential divestiture of the underperforming phosphate segment could unlock value and fund strategic growth, notably a $1B US potash terminal.
NTR is riding strong fertilizer demand, cost cuts, and strategic deals despite pressure from rising input costs.
NTR's sharp Q3 expense cuts boost profitability and Retail margins, underscoring how cost discipline is strengthening its resilience in a mixed market.
Nutrien and CF Industries ride firm fertilizer demand, rising prices and stronger cash flow as global farm economics stay supportive.
NTR's 27% YTD rally, rising fertilizer demand and cost cuts power its momentum even as input cost volatility lingers.
NTR posts a sharp profit increase on stronger sales across segments and lifts Potash volume guidance for 2025.
The headline numbers for Nutrien (NTR) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Nutrien (NTR) came out with quarterly earnings of $0.97 per share, beating the Zacks Consensus Estimate of $0.93 per share. This compares to earnings of $0.39 per share a year ago.
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Nutrien (NTR), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.